The St. Baldrick's Foundation is a volunteer and donor powered charity committed to supporting the most promising research to find cures for childhood cancers and give survivors long and healthy lives.
It started with a friendly dare: would you shave your head to raise money for kids’ cancer research? What happened next would change the world. This bold act of baldness has gained major momentum, since its start in 2000. Today, we have more than 1,000 head-shaving events taking place around the world at pubs, restaurants, schools, churches, parks, firehouses, military bases – you name it. It is our constituents’ way of changing the world, in a meaningful way. Volunteers also raise funds through athletic challenges, livestream fundraisers and many other activities. Since the Foundation's first grants as an independent charity in 2005, St. Baldrick's has invested more than $352 million in childhood cancer research grants worldwide. It’s about collaboration. It’s about powerful ideas, big and small. It’s about never giving up until we have cures for all kids with cancers.
For more information, please visit StBaldricks.org. You can also search current and past grants at StBaldricks.org/grants.
FUNDING HIGHLIGHTS
The St. Baldrick’s Foundation works hard to be sure that every dollar makes the biggest impact possible in childhood cancer research. The Foundation is proud to have received the National Cancer Institute Peer Review Funder designation for selection of grants. The Foundation has held several Research Priorities Summits with many of the country’s leading pediatric oncology researchers participating to advise the staff and board of directors on funding priorities. The St. Baldrick’s team and scientific advisors meet regularly to be sure St. Baldrick’s funds make the greatest impact on pediatric cancer research.
Current funding priorities are divided into four categories:
• New discovery research
• Translational research and early phase clinical trials
• Phase III clinical trials & infrastructure support of participating institutions (primarily the fall grant cycle)
• Education of new pediatric oncology researchers
In addition to research to understand the biology of childhood cancers and discover leads to more effective treatments, topics of interest include, but are not limited to:
• Adolescents & young adults
• Survivorship, outcomes, and quality of life
• Supportive care
• Epidemiology and pediatric cancer predispositions
• Precision medicine
• Alternative & complementary therapies
FUNDING CYCLES
Spring Grant Cycle
Spring cycle grants are funded based on scientific review.
The following programs/categories are available in the Spring Cycle:
• St. Baldrick’s Scholars
• St. Baldrick’s International Scholars
• Research Grants
St. Baldrick’s Summer Fellows (no LOI, applications due February)
Fall Grant Cycle
Fellows are funded based on scientific review. Infrastructure grants are funded based on need, expected outcomes, and local St. Baldrick’s participation, with a strong priority on geographic areas with no other St. Baldrick’s funding.
The following programs/categories are available in the Fall Cycle:
• Infrastructure Grants
• St. Baldrick’s Fellows
Grants will be made according to revenues available.
The Scholar (Career Development) Award is meant to help develop the independent research of highly qualified individuals still early in their careers. Recipients are called St. Baldrick’s Scholars. Grants will be up to $110,000/year, for three years.
• Scholar Awards are one of many funding categories offered by the St. Baldrick’s Foundation; it is possible for a program/institution to receive funding in more than one category. With the exception noted immediately below, each program/institution may submit one LOI/application in all open St. Baldrick’s funding categories.
2025 St. Baldrick's Spring Cycle LOI/application submissions allowed by program/category per institution
Program/category
Research Grant 1
Scholar (CDA) 1
International Scholar 1
Limited submission policy exception1
If an institution submitted the total number of LOI/applications allowed, this would be 4 submissions total
*See details below for areas of interest that qualify for the one additional exception submission in one category of choice
• ATTENTION: limited submissions policy exception: Due to high interest from donors and low numbers of past applications, an additional LOI/application will be accepted only if focused on one of the following. This is one additional LOI/application overall for the cycle, not one additional LOI/application per program/category.
Brain tumors – all types, including rare forms, especially atypical teratoid/rhabdoid tumor (AT/RT), diffuse intrinsic pontine glioma (DIPG)/diffuse midline glioma (DMG), and glioblastoma (GBM)
Burkitt lymphoma – all types, especially sporadic
Ewing sarcoma
Rhabdoid tumors - Extrarenal
• During each grant cycle, an applicant can only apply once as the lead Principal Investigator. This restriction applies also to the above described limited submissions policy exception.
• Institutions must be located in the United States.
• Applicants need not be American citizens; however, they must work at an academic, medical, or research institution within the United States.
• Applicants from the NCI/NIH are not eligible to apply for St. Baldrick’s Scholar Awards.
• A program/institution is defined as an entity essentially operating under one management.
o Any questions or questionable situations will be reviewed by a subset of the Scientific Advisory Board of St. Baldrick’s. Questions can be emailed to Grants@Stbaldricks.org, please include a copy of the potential Scholar’s biosketch.
• Institutions that are actively involved in (sponsor, promote, or participate in) non-St. Baldrick’s head-shaving fundraising events are not eligible to apply for St. Baldrick’s funding.
o St. Baldrick’s understands that hospitals and their fundraising agents and organizations cannot control what their many volunteers do. Some may undertake head-shaving fundraisers that hospital/agent/organization is not aware of and does not sanction or promote. These activities would not prevent the hospital’s researchers from applying for St. Baldrick’s grants.
o The following applies to hospitals, their fundraising agents and organizations as institutions. Researchers from hospitals would be ineligible to apply for St. Baldrick’s grants if the hospital/agent/organization promotes (advertises, emails, blogs, media stories, social media posts, shares, reshares, likes, tweets, re-tweets or hosts web pages) a non-St. Baldrick’s head-shaving fundraiser through any type of marketing, advertising, outreach or public-facing collateral or ancillary materials, or on any channel (television, radio, print, social media, website, etc.), using any content that sponsors, highlights, advocates or recommends a head-shaving event other than St. Baldrick’s.
• St. Baldrick’s funds may not be used for human embryonic stem cell research.
• All awards will be payable to the academic institution, non-profit research institution, or laboratory to administer for the purposes of this grant only.
• All qualified applicants will receive consideration for funding without regard to race, color, ethnicity/national origin, sex, sexual orientation, gender identity or expression, pregnancy, religion, belief and spirituality, age disability status, protected veteran status, or any other characteristic protected by law.
• Applicants should hold a Ph.D., M.D., or D.O. degree in a field of research specialty by the date the award becomes effective.
• Applicants must be employed by an academic or non-profit research institution or laboratory.
• Applicants must currently hold (for no longer than 7 years at the time the award begins), or will hold by start of the award, a title that is considered by the institution to be a full-time, faculty position.
o Faculty position should not depend upon the awarding of this Scholar grant.
o Situations may occur where the institutions definition of “faculty” may differ from the Foundation’s definition, this should be fully explained in the Scholar Applicant Checklist (required at LOI stage).
• This is an early-career award. The Scholar award is intended to develop the independent pediatric cancer research careers of highly qualified investigators, not to support well established or senior investigators.
• Scholars may receive funding from other sources to support their research. However, no other comparable or higher (monetary value) career development award may be held prior to or at the time the award begins. Scientific or budgetary overlap with other funded projects is not allowed.
o In the event of comparable or higher (monetary value) career development funding after the LOI has been approved, the Scholar must give up the remainder of their St. Baldrick’s award, unless otherwise approved by the St. Baldrick’s Foundation.
• Applicants holding or awarded R01s at the time of the LOI are not eligible to apply. Applicants cannot hold a NIH K-award at the time that they apply (institutional K12 funding is allowable). See “Conditions of Award” below regarding other awards received after the LOI is approved.
• Applicants must have an appropriate Sponsor who provides supervision, facilities, and research support. If appropriate for the project, applicants may have more than one (1) Sponsor.
• Research projects must have direct applicability and relevance to pediatric cancer. They may be in any discipline of basic, clinical, translational, or epidemiological research.
• This award is granted for three years with an opportunity to apply for an additional two years of funding based upon the demonstration of significant accomplishment. (Years 4–5, if funded, will be up to $115,000/year).
Sponsor Institute/Organizations: St. Baldrick's Foundation
Address: 1333 South Mayflower Avenue, Suite 400 Monrovia, CA 91016 USA (888) 899‑2253 · sbinfo@stbaldricks.org
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Dec 09, 2024
Feb 28, 2025
$110,000
Affiliation: St. Baldrick's Foundation
Address: 1333 South Mayflower Avenue, Suite 400 Monrovia, CA 91016 USA (888) 899‑2253 · sbinfo@stbaldricks.org
Website URL: https://www.stbaldricks.org/for-researchers
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.
Commonly asked questions about this funding opportunity from the host and other attendees.